Sodium Glucoheptonate Dihydrate

CAS: 31138-65-5

Ref. 3D-GBA13865

Product Information

• Name: Sodium Glucoheptonate Dihydrate
• Synonyms: <span class="text-smallcaps">D</span>-Glucoheptonic acid, monosodium salt, <span class="text-smallcaps">D</span>-gluco-Heptonic acid, monosodium salt, (2ξ)-, <span class="text-smallcaps">D</span>-gluco-Heptonic acid, sodium salt (1:1), (2ξ)-, Cheelox 354, D-Gluco-heptonic acid, monosodium salt, (2.xi)-, D-gluco-Heptonic acid, monosodium salt, (2xi)-, D-gluco-Heptonic acid, sodium salt (1:1), (2xi)-, D-glycero-D-gulo-Heptonic acid, monosodium salt, D-glycero-D-gulo-Heptonic acid, sodium salt (1:1), Gluceptate Sodium, Monosodium D-glucoheptonate, Monosodium D-glycero-D-gulo-heptonate, Monosodium glucoheptonate, Sodium D-glycero-D-gulo-heptonate, Unii-3D49Le7Hm2, sodium (2R,3R,4S,5R,6R)-2,3,4,5,6,7-hexahydroxyheptanoate (non-preferred name), sodium (3R,4S,5R,6R)-2,3,4,5,6,7-hexahydroxyheptanoate (non-preferred name), Sodium glucoheptonate, D-gluco-Heptonic acid, monosodium salt, (2ξ)-, D-Glucoheptonic acid, monosodium salt, D-gluco-Heptonic acid, sodium salt (1:1), (2ξ)-

Description

Sodium glucoheptonate is a heptapeptide that acts as a receptor activator. It has been shown to inhibit the growth of prostate cancer cells by blocking the production of fatty acids and glycol ethers. Sodium glucoheptonate also inhibits the production of epidermal growth factor (EGF) in human breast cancer cells and may be used for the treatment of EGF-dependent tumors. Sodium glucoheptonate has been shown to have cardioprotective effects, as it can reduce myocardial infarct size and improve cardiac function following myocardial infarction. This drug also has detergent activity and can be used in detergent compositions for cleaning purposes.

• Brand: Biosynth

Chemical properties

• Molecular weight: 284.19 g/mol
• Formula: C₇H₁₇NaO₁₀
• Purity: Min. 95%